Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Climb Bio (CLYM) Income from Non-Controlling Interests (2020 - 2022)

Climb Bio filings provide 3 years of Income from Non-Controlling Interests readings, the most recent being -$13.6 million for Q1 2022.

  • Quarterly Income from Non-Controlling Interests rose 26.87% to -$13.6 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was -$52.5 million through Mar 2022, changed N/A year-over-year, with the annual reading at -$47.6 million for FY2021, 130.32% down from the prior year.
  • Income from Non-Controlling Interests hit -$13.6 million in Q1 2022 for Climb Bio, down from -$10.6 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$2.3 million in Q3 2020 and bottomed at -$18.6 million in Q1 2021.
  • Average Income from Non-Controlling Interests over 3 years is -$11.6 million, with a median of -$12.1 million recorded in 2021.
  • Peak annual rise in Income from Non-Controlling Interests hit 28.35% in 2021, while the deepest fall reached 326.62% in 2021.
  • Climb Bio's Income from Non-Controlling Interests stood at -$14.9 million in 2020, then increased by 28.35% to -$10.6 million in 2021, then dropped by 27.72% to -$13.6 million in 2022.
  • Per Business Quant, the three most recent readings for CLYM's Income from Non-Controlling Interests are -$13.6 million (Q1 2022), -$10.6 million (Q4 2021), and -$9.6 million (Q3 2021).